Copart Now Covered by Stephens (CPRT)

Stephens assumed coverage on shares of Copart (NASDAQ: CPRT) in a report issued on Friday. The firm issued an equal weight rating on the stock.

Shares of Copart traded up 0.04% during mid-day trading on Friday, hitting $34.325. Copart has a one year low of $22.59 and a one year high of $37.47. The stock’s 50-day moving average is currently $33.84. The company has a market cap of $4.283 billion and a P/E ratio of 23.81.

CPRT has been the subject of a number of other recent research reports. Analysts at Robert W. Baird downgraded shares of Copart from an outperform rating to a neutral rating in a research note to investors on Monday, February 4th. They now have a $36.00 price target on the stock, up previously from $33.00. They noted that the move was a valuation call. Separately, analysts at BB&T upgraded shares of Copart from a hold rating to a buy rating in a research note to investors on Friday, February 1st. Finally, analysts at BB&T downgraded shares of Copart from a buy rating to a hold rating in a research note to investors on Friday, February 1st.

One research analyst has rated the stock with a buy rating, six have assigned a hold rating, one has given an underweight rating, and one has given a sell rating to the company’s stock. Copart currently has a consensus rating of hold and an average price target of $30.75.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Google Spends $1 Billion To Purchase Waze
Google Spends $1 Billion To Purchase Waze
Apple Exploring Options In Net Radio
Apple Exploring Options In Net Radio
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Aaron Hernandez, New England Patriots Player has House Searched
Aaron Hernandez, New England Patriots Player has House Searched
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe